Electronic memorandum decreases unnecessary antimicrobial use for asymptomatic bacteriuria and culture-negative pyuria.

Veterans Affairs Boston Health Care System, Boston, Massachusetts 02132, USA.
Infection Control and Hospital Epidemiology (Impact Factor: 3.94). 07/2011; 32(7):644-8. DOI: 10.1086/660764
Source: PubMed

ABSTRACT Asymptomatic bacteriuria/candidiuria (ASB) and culture-negative pyuria (CNP) are common and often result in inappropriate antibiotic use. We aimed to evaluate whether a standardized educational memorandum could reduce antimicrobial utilization for ASB/CNP.
Quasi-experimental study with a control group, from a convenience sample of inpatients with abnormal urinalysis or urine culture results in a Veterans Affairs hospital.
An educational memorandum outlining guidelines for diagnosis and treatment of ASB was placed in the chart of patients with ASB/CNP who were receiving antimicrobials.
The records of patients meeting inclusion criteria were abstracted for demographics, comorbidities, antimicrobials, and symptoms suggestive of possible urinary tract infection (UTI). Patients were categorized as having ASB, CNP, or UTI. The number of antimicrobial-days attributed to ASB/CNP was compared between the control group and the intervention group.
Charts of 301 patients with abnormal urine results were reviewed. Thirty of 117 (26%) patients in the control group received antimicrobials for ASB/CNP for an average of 6.3 days. In the intervention group, 24 of 92 (26%) patients received antimicrobials for ASB/CNP for an average of 2.2 days (t-test: P < .001). Adverse events from antimicrobials for ASB/CNP occurred in 3 of the 30 (10%) patients in the control group. There were no adverse events from untreated ASB/CNP in the intervention group.
ASB and CNP resulted in antimicrobial exposure in more than one-quarter of our study patients. Placing a standardized memorandum in the electronic record was associated with a 65% relative reduction in antimicrobial-days for ASB and CNP.


Available from: Kalpana Gupta, Feb 11, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: We sought to prevent the initiation of antimicrobial therapy for asymptomatic bacteriuria (ASB) by providing audit and feedback of newly reported positive urine cultures to test whether this could empower providers to leave ASB untreated. Despite success in providing feedback before antibiotics could be initiated in most cases, these recommendations only reduced treatment duration, without affecting antibiotic initiation. This study highlights the limitations of educational initiatives in overcoming engrained beliefs about bacteriuria even when advice is provided in real time.
    American Journal of Infection Control 10/2014; 42(10):1136-7. DOI:10.1016/j.ajic.2014.06.020 · 2.33 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Rapid urine tests for infection (urinalysis, dipstick) have low up-front costs. However, many false positives occur, with important downstream consequences, including unnecessary antibiotics. We studied indications, collection technique, and results of urinalyses in acute care. This research was a prospective observational study of a convenience sample of emergency department (ED) patients who had urinalysis performed between June 1, 2012 and February 15, 2013 at an urban teaching hospital. Analyses were conducted via t tests, χ(2) tests, and multivariable logistic regression. Of 195 cases included in the study, the median age was 56 and 70% of participants were female. There were specific symptoms or signs of urinary tract infection (UTI) in 74 cases (38%; 95% confidence interval [CI], 31%-45%), nonspecific symptoms or signs in 83 cases (43%; 95% CI, 36%-50%), and no symptoms or signs of UTI in 38 cases (19%; 95% CI, 14%-25%). The median age was 51 (specific symptoms), 58 (nonspecific symptoms), and 61 (no symptoms), respectively (P = .005). Of 137 patients who produced the specimen without assistance, 78 (57%; 95% CI, 48%-65%) received no instructions on urine collection. Correct midstream clean-catch technique was used in 8 of 137 cases (6%). Presence of symptoms or signs was not associated with a new antibiotic prescription, but positive urinalysis (OR, 4.9; 95% CI, 1.7-14) and positive urine culture (OR, 3.6; 95% CI, 1.1-12) were. Of 36 patients receiving antibiotics, 10 (28%; 95% CI, 13%-43%) had no symptoms or nonspecific symptoms. In this sample at an urban teaching hospital ED, urine testing was not driven by symptoms. Improving practice may lower costs, improve efficiency of care, decrease unnecessary data that can distract providers and impair patient safety, decrease misdiagnosis, and decrease unnecessary antibiotics.
    03/2014; 1(1):ofu019. DOI:10.1093/ofid/ofu019
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objectif Décrire les tableaux cliniques associés aux ECBU positifs à Escherichia coli BLSE et leur impact sur l’utilisation d’antibiotiques. Méthodes Étude observationnelle, prospective, dans 13 hôpitaux d’Île-de-France pendant 3 mois consécutifs. Inclusion de tous les patients avec ECBU positif en culture à E. coli BLSE. Résultats Ont été inclus 218 patients. Le diagnostic de colonisation était retenu pour 117 cas (54 %). Les infections (101 cas, 46 %) se répartissaient en 31 cystites (14 %) et 70 infections parenchymateuses (32 %). Dix-neuf patients avec colonisation urinaire (16 %) ont reçu des antibiotiques. Dans 41 infections parenchymateuses (59 %) l’antibiothérapie comportait un carbapénème. Selon les données de l’antibiogramme, une alternative à l’utilisation d’un carbapénème aurait pu être utilisée chez tous les patients traités par carbapénème. Conclusion Les infections urinaires représentaient 46 % des ECBU positifs à E. coli BLSE. Cinquante pour cent des infections urinaires parenchymateuses ont été traitées par un carbapénème.
    Médecine et Maladies Infectieuses 10/2014; 44(11-12). DOI:10.1016/j.medmal.2014.09.004 · 0.91 Impact Factor